Unlock Premium Data: Up to 50% Off InvestingProCLAIM SALE

Revvity Inc. executive sells over $440k in company stock

Published 11/06/2024, 06:10 am
RVTY
-

Revvity Inc. (NYSE:RVTY) has reported a notable transaction involving its senior executive, Joel S. Goldberg, who serves as the Senior Vice President, Administration, General Counsel, and Secretary of the company. Goldberg executed a sale of company shares valued at over $440,000, according to a recent filing with the Securities and Exchange Commission.

The transaction, which took place on June 7, 2024, involved Goldberg selling a total of 4,000 shares of Revvity Inc. common stock. The shares were sold at prices ranging from $110.32 to $110.80, with the total transaction amounting to approximately $441,844. This sale was conducted under a 10b5-1 trading plan, which was previously adopted by Goldberg on February 7, 2024.

Investors and the market often monitor insider transactions such as these for insights into executive sentiment regarding the company's stock performance and future prospects. While the reasons behind Goldberg's decision to sell shares are not specified in the report, the execution of the sale under a pre-arranged trading plan suggests that it was not based on any immediate knowledge of internal corporate matters.

Following the sale, Goldberg's direct holdings in Revvity Inc. have been adjusted to reflect the new total of shares owned. It's worth noting that Goldberg also has an indirect interest in additional shares held in an irrevocable trust for the benefit of his children, over which he disclaims beneficial ownership, except to the extent of any pecuniary interest he may have.

Revvity Inc., known for its work in the laboratory analytical instruments sector, has undergone several name changes in its history, previously known as PerkinElmer Inc (NYSE:RVTY)., EG&G Inc., and Edgerton Germeshausen & Grier Inc. The company is incorporated in Massachusetts and has its headquarters in Waltham, MA.

Investors and shareholders of Revvity Inc. continue to observe insider trading activity for indications of the company's financial health and trajectory. As of now, the company has not issued any statements regarding the recent insider stock sale.

In other recent news, Revvity Inc. has been in the spotlight with its first-quarter results and subsequent analysis by financial firms. The company exceeded expectations in its first-quarter results, with revenue matching projections and earnings per share slightly surpassing estimates. This strong performance led TD Cowen to raise Revvity's price target from $123.00 to $130.00, maintaining a Buy rating on the stock. Similarly, Baird increased the price target by a dollar to $127, reaffirming an Outperform rating.

Despite a 3% decline in organic revenue and a softer spending environment in the pharmaceutical and biotech sectors, Revvity managed to focus on operational efficiency, resulting in an impressive adjusted operating margin of 25.5%. The company generated over $130 million in free cash flow and remains optimistic about future growth, maintaining its full-year outlook.

Analysts from both TD Cowen and Baird highlighted Revvity's solid performance and potential for future growth, with TD Cowen pointing out the company's strategies to potentially expand margins. These recent developments shed light on Revvity's resilience and its ability to navigate market headwinds while maintaining a steady growth trajectory.

InvestingPro Insights

Amidst the insider trading activity at Revvity Inc. (NYSE:RVTY), investors are keen to understand the company's financial positioning and future outlook. Utilizing InvestingPro data, one can gain a deeper insight into Revvity's current market performance and valuation.

Revvity's market capitalization stands at a robust $13.48 billion, reflecting the company's significant presence in its sector. Despite this, the company's P/E ratio is notably high at 90.36, which might raise questions about its valuation. However, when adjusted for the last twelve months as of Q1 2024, the P/E ratio appears more moderate at 37.37. This suggests that while the stock may be trading at a premium, it might be supported by earnings growth expectations.

InvestingPro Tips highlight that management at Revvity has been aggressively buying back shares, a move that can be interpreted as a sign of confidence in the company's future performance. Additionally, Revvity is recognized for its high shareholder yield and has a history of maintaining dividend payments for 54 consecutive years, which is a testament to its commitment to shareholder returns.

For those considering a deeper analysis of Revvity Inc., InvestingPro offers a suite of additional tips. There are currently 11 tips available, which can be accessed through the dedicated page for Revvity at https://www.investing.com/pro/RVTY. Interested investors can use the coupon code PRONEWS24 to get an additional 10% off a yearly or biyearly Pro and Pro+ subscription, further enriching their investment decision-making process with valuable insights.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.